**US20825C1045 - Common Stock - After market: 99.74 -0.01 (-0.01%)**

We assign a fundamental rating of **7** out of 10 to **COP**. **COP** was compared to 385 industry peers in the **Oil, Gas & Consumable Fuels** industry. **COP** scores excellent points on both the profitability and health parts. This is a solid base for a good stock. **COP** is not valued too expensively and it also shows a decent growth rate. **COP** also gives a nice dividend, which makes it suited for dividend investing!.

ROA (19.91%) VS Industry: 73% outperformed.

0.06

1,708.00

ROE (38.91%) VS Industry: 69% outperformed.

0.30

19,161.80

Profit Margin (23.8%) VS Industry: 44% outperformed.

0.07

334.14

With a **Price/Earnings Ratio** of **7.39**, the valuation of **COP** can be described as very cheap.

With a **Forward Price/Earnings Ratio** of **9.26**, the valuation of **COP** can be described as very reasonable.

With a price book ratio of **2.53**, **COP** is valued correctly.

Compared to an average industry **Enterprise Value to EBITDA** ratio of 3.70, **COP** is valued in line with its industry peers.

Compared to an average industry price book ratio of 1.45, **COP** is valued more expensive than its industry peers.

Price/Earnings (7.39) VS Industry: 38% outperformed.

4,750.00

0.01

Price/Book (2.53) VS Industry: 27% outperformed.

3,984.80

0.04

Enterprise Value/ EBITDA (3.72) VS Industry: 49% outperformed.

227.31

0.12

Looking at the last year, **COP** shows a very strong growth in **Revenue**. The Revenue has grown by **71.28%**.

The **Revenue** has been growing by **21.57%** on average over the past 5 years. This is a very strong growth!

Based on estimates for the next 5 years, **COP** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-5.22%** on average per year.

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Based on estimates for the next 5 years, **COP** will show a very negative growth in **Revenue**. The Revenue will decrease by **-12.90%** on average per year.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 79.2% | 55.47% | 124.83% | -20.11% | -10.37% | -11.74% | -5.22% |

Revenue | 21.57% | 34.27% | 71.28% | -13.91% | -8.08% | -9.67% | -12.9% |

When comparing the Altman-Z score to an average industry score of **2.05**, **COP** is in better financial health than the average industry peer.

The Debt to Equity ratio of **COP** is in line with the industry averages.

Debt/Equity (0.34) VS Industry: 43% outperformed.

78.08

0.00

Quick Ratio (1.36) VS Industry: 63% outperformed.

0.00

279.52

Current Ratio (1.46) VS Industry: 62% outperformed.

0.00

279.52

Altman-Z (4.18) VS Industry: 77% outperformed.

-283,883.16

804.85

Compared to an average S&P500 **Dividend Yield** of **2.60**, **COP** pays a better dividend.

The dividend of **COP** is nicely growing with an annual growth rate of **55.19%**!

Compared to an average industry **Dividend Yield** of **5.67**, **COP** has a dividend in line with its industry peers.

The **Dividend Rate** of **COP** has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.

Dividend Yield (5.66%) VS Industry: 49% outperformed.

0.32

64.51

NYSE:COP (3/29/2023, 7:04:01 PM)**+1.82 (+1.86%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)02-02 2023-02-02/bmo

Earnings (Next)05-03 2023-05-03/bmo

Inst Owners82.9%

Inst Owner Change-0.77%

Ins Owners0.08%

Ins Owner Change5.9%

Market Cap121.57B

Analysts79.39

Price Target138.84 (39.19%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 5.66% |

Dividend Growth(5Y)55.19%

DP30.65%

Div Incr Years6

Div Non Decr Years6

Ex-Date03-28 2023-03-28 (0.6)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-0.77%

Min EPS beat(2)-4.53%

Max EPS beat(2)3%

EPS beat(4)3

Avg EPS beat(4)1.78%

Min EPS beat(4)-4.53%

Max EPS beat(4)6.88%

Revenue beat(2)2

Avg Revenue beat(2)7.3%

Min Revenue beat(2)1.93%

Max Revenue beat(2)12.66%

Revenue beat(4)4

Avg Revenue beat(4)7.08%

Min Revenue beat(4)1.93%

Max Revenue beat(4)12.66%

PT rev (1m)-1.45%

PT rev (3m)-1.84%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-25.69%

EPS NY rev (1m)-18.1%

EPS NY rev (3m)-18.1%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-9.63%

Revenue NY rev (1m)-0.58%

Revenue NY rev (3m)-0.58%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 7.39 | ||

Fwd PE | 9.26 | ||

P/S | 1.55 | ||

P/FCF | 6.7 | ||

P/OCF | 4.29 | ||

P/B | 2.53 | ||

P/tB | 2.53 | ||

EV/EBITDA | 3.72 |

EPS(TTM)13.49

EY13.52%

EPS(NY)10.78

Fwd EY10.8%

FCF(TTM)14.9

FCFY14.93%

OCF(TTM)23.23

OCFY23.29%

SpS64.4

BVpS39.39

TBVpS39.39

PEG (NY)N/A

PEG (5Y)0.09

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 19.91% | ||

ROE | 38.91% | ||

ROIC | 20.71% | ||

ROICexc | 23.37% | ||

ROICexgc | 23.37% | ||

OM | 32.94% | ||

PM | 23.8% | ||

GM | 47.8% |

ROICexgc(3y)N/A

ROICexcg growth 3Y41.46%

ROICexcg growth 5Y55.69%

ROICexc(3y)N/A

ROICexc growth 3Y41.46%

ROICexc growth 5Y55.69%

OM growth 3Y14.86%

OM growth 5Y34.68%

PM growth 3Y2.39%

PM growth 5YN/A

GM growth 3Y0.26%

GM growth 5Y3.37%

F-Score8

Asset Turnover0.84

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.34 | ||

Debt/FCF | 0.92 | ||

Debt/EBITDA | 0.5 | ||

Cap/Depr | 135.38% | ||

Profit Quality | 97.19% | ||

Current Ratio | 1.46 | ||

Quick Ratio | 1.36 | ||

Altman-Z | 4.18 |

F-Score8

WACC10.38%

ROIC/WACC2.25

Cap/Depr(3y)98.21%

Cap/Depr(5y)103.39%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y124.83%

EPS 3Y55.47%

EPS 5Y79.2%

EPS growth Q2Q19.38%

EPS Next Y-20.11%

EPS Next 2Y-10.37%

EPS Next 3Y-11.74%

EPS Next 5Y-5.22%

Revenue growth 1Y71.28%

Revenue growth 3Y34.27%

Revenue growth 5Y21.57%

Revenue growth Q2Q22.74%

Revenue Next Year-13.91%

Revenue Next 2Y-8.08%

Revenue Next 3Y-9.67%

Revenue Next 5Y-12.9%

EBIT growth 1Y116.06%

EBIT growth 3Y54.23%

EBIT growth 5Y63.73%

EBIT Next Year2.05%

EBIT Next 3Y-4.03%

EBIT Next 5Y-6.05%

FCF growth 1Y55.54%

FCF growth 3Y59.57%

FCF growth 5Y48.83%

OCF growth 1Y66.59%

OCF growth 3Y36.62%

OCF growth 5Y31.96%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*